These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy. Patton J, Kuzur M, Liggett W, Miranda F, Varsos H, Porter L. Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018 [Abstract] [Full Text] [Related]
8. Interventions for anemia in pediatric cancer patients. Ruggiero A, Riccardi R. Med Pediatr Oncol; 2002 Oct; 39(4):451-4. PubMed ID: 12203662 [Abstract] [Full Text] [Related]
9. Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy. Schouwink JH, Codrington H, Sleeboom HP, Kerkhofs LG, Wormhoudt LW. Eur J Cancer; 2008 Apr; 44(6):819-29. PubMed ID: 18343652 [Abstract] [Full Text] [Related]
10. Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer. Welch RS, James RD, Wilkinson PM, Belli F, Cowan RA. Cancer J Sci Am; 1995 Apr; 1(4):261-6. PubMed ID: 9166486 [Abstract] [Full Text] [Related]
19. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level. Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G. Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841 [Abstract] [Full Text] [Related]